A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)
Status:
COMPLETED
Trial end date:
2025-03-14
Target enrollment:
Participant gender:
Summary
FOCUS (Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol) is a Phase 3, multi-center, randomized, double-blind, placebo-controlled, parallel- group trial to assess the efficacy and safety of solriamfetol in adults with ADHD.